Trial Profile
Randomized, single-center, open-label safety and pharmacokinetics study of Pirfenidone and its metabolite 5-carboxy-pirfenidone in chinese volunteers in fed condition
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Oct 2015
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Pharmacokinetics
- 20 Oct 2015 New trial record